益气逐瘀方治疗早期脊髓型颈椎病临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R681.5+3

基金项目:

江苏省苏州市卫计委青年基金项目( KJXW2016036)


Clinical Study on Yiqi Zhuyu Prescription for Early Cervical Spondylotic Myelopathy
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察益气逐瘀方治疗早期脊髓型颈椎病的临床疗效。方法:选取40例早期脊髓型颈椎病患者为研究对象,按照区组随机化方法分为对照组和治疗组,每组20例。对照组给予美洛昔康片、盐酸乙哌立松片治疗,治疗组给予益气逐瘀方治疗。对比观察2组患者治疗前后日本骨科协会(JOA)颈椎病评分和视觉模拟评分法(VAS)评分,采用富田庄司提出的方法检测颈椎突出物吸收率和突出率。结果:2组JOA颈椎病评分在治疗2周、3个月、6个月后与治疗前比较,差异均有统计学意义(P<0.05)。治疗组治疗3个月、6个月JOA颈椎病评分均高于同期对照组,差异均有统计学意义(P<0.05)。2组VAS评分在治疗2周、3个月、6个月后与治疗前比较,差异均有统计学意义(P<0.05)。治疗组治疗3个月、6个月VAS评分均低于同期对照组,差异均有统计学意义(P<0.05)。治疗后,治疗组颈椎间盘突出率较治疗前减小,对照组颈椎间盘突出率较治疗前增大,差异均有统计学意义(P<0.05)。治疗组颈椎间盘突出物吸收率高于对照组,差异有统计学意义(P<0.05)。结论:益气逐瘀方能有效缓解早期脊髓型颈椎病患者的颈痛症状,延缓病情进展,具有更好的远期疗效。

    Abstract:

    Objective:To observe the clinical effect of Yiqi Zhuyu prescription for early cervical spondylotic myelopathy.Methods:A total of 40 patients with early cervical spondylotic myelopathy were selected and divided into the control group and the treatment group according to the block randomization,20 patients in each group.The control group was treated with meloxicam tablets and eperisone hydrochloride tablets,while the treatment group was treated with Yiqi Zhuyu prescription.The scores of cervical spondylosis of Japanese Orthopaedic Association(JOA)and visual analogue scale(VAS)were compared and observed before and after treatment in the two groups.The absorption rate and protrusion rate of cervical disc herniation were measured by the method proposed by Tomita Shoji.Results:Compared the scores of JOA in the two groups two weeks,three months and six months after treatment with those before treatment respectively,there were significant differences(P<0.05).The JOA score in the treatment group was higher than that in the control group three months and six months after treatment,differences being significant(P < 0.05).Compared the VAS scores in the two groups two weeks,three months and six months after treatment with those before treatment respectively,there were significant differences(P<0.05).The VAS score in the treatment group was higher than that in the control group three months and six months after treatment,differences being significant(P<0.05).The protrusion rate of cervical disc herniation in the treatment group was decreased when compared with that before treatment,while that in the control group was increased when compared with that before treatment,differences being significant(P< 0.05).The absorption rate of cervical disc herniation in the treatment group was higher than that in the control group,the difference being significant(P<0.05).Conclusion:Yiqi Zhuyu prescription can effectively alleviate the symptoms of neck pain in patients with early cervical spondylotic myelopathy,delay the continuous development of the disease,and has better long-term effect.

    参考文献
    相似文献
    引证文献
引用本文

马智佳,姜宏,俞鹏飞,刘锦涛,张志刚,李红卫.益气逐瘀方治疗早期脊髓型颈椎病临床研究[J].新中医,2020,52(1):98-101

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2020-01-06
  • 出版日期: